November 7, 2022
Via: PharmaphorumArtificial Intelligence (AI) and deep learning have already transformed several aspects of small molecule drug design. Recent advances in the area are now also impacting more complex tasks, such as design and optimisation of antibodies. As a result, 2022 saw […]
September 10, 2021
Via: PMLiVEBoehringer Ingelheim will use the same concept in a new research collaboration with San Francisco-based Twist Bioscience, harnessing its antibody libraries to discover therapeutic antibodies that work against a range of BI targets. Twist’s ability to manufacture DNA at scale […]
July 19, 2024
July 11, 2024
July 11, 2024
Copyright © 2024. All rights reserved
